Moreover, the activation of PPARdelta induces neuroprotection and reverses neurodegeneration in Alzheimer’s disease (Tong et al., 2016), Parkinson’s disease (Martin et al., 2013) and Huntington’s disease (Dickey et al., 2016). Here, PPARD is linked to juvenile Huntington disease.